References
- Aslani N, Janbabaei G, Abastabar M, Meis JF, Babaeian M, Khodavaisy S, Boekhout T, Badali H. 2018. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry. BMC Infect Dis. 18:24. doi:https://doi.org/10.1186/s12879-017-2916-5
- Bozó A, Domán M, Majoros L, Kardos G, Varga I, Kovács R. 2016. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model. J Microbiol. 54:753–760. doi:https://doi.org/10.1007/s12275-016-6298-y
- Cordeiro RA, Teixeira CE, Brilhante RS, Castelo-Branco DS, Paiva MA, Giffoni Leite JJ. 2013. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol. Med Mycol. 51:53–59.
- Elahi S, Pang G, Clancy R, Ashman RB. 2000. Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect Immun. 68:5771–5777. doi:https://doi.org/10.1128/IAI.68.10.5771-5777.2000
- Fabio CA, Yolanda MB, Carmen GM, Francisco C, Julián BA, Leonor PL, Jesús S. 2016. Use of photodynamic therapy and chitosan for inactivacion of Candida albicans in a murine model. J Oral Pathol Med. 45:627–633. [PubMed: 26991463] doi:https://doi.org/10.1111/jop.12435
- Fernandes RA, Monteiro DR, Arias LS, Fernandes GL, Delbem AC, Barbosa DB. 2016. Biofilm formation by Candida albicans and Streptococcus mutans in the presence of farnesol: a quantitative evaluation. Biofouling. 32:329–338. doi:https://doi.org/10.1080/08927014.2016.1144053
- Hayama K, Ishibashi H, Ishijima SA, Niimi K, Tansho S, Ono Y, Monk BC, Holmes AR, Harding DRK, Cannon RD, et al. 2012. A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model. FEMS Microbiol Lett. 328:130–137. doi:https://doi.org/10.1111/j.1574-6968.2011.02490.x
- Hebecker B, Naglik JR, Hube B, Jacobsen ID. 2014. Pathogenicity mechanisms and host response during oral Candida albicans infections. Expert Rev Anti Infect Ther. 12:867–879. doi:https://doi.org/10.1586/14787210.2014.916210
- Hisajima T, Maruyama N, Tanabe Y, Ishibashi H, Yamada T, Makimura K, Nishiyama Y, Funakoshi K, Oshima H, Abe S. 2008. Protective effects of farnesol against oral candidiasis in mice. Microbiol Immunol. 52:327–333. doi:https://doi.org/10.1111/j.1348-0421.2008.00044.x
- Ishibashi H, Uchida K, Nishiyama Y, Yamaguchi H, Abe S. 2007. Oral administration of itraconazole solution has superior efficacy in experimental oral and oesophageal candidiasis in mice than its intragastric administration. J Antimicrob Chemother. 59:317–320. doi:https://doi.org/10.1093/jac/dkl472
- Katragkou A, McCarthy M, Alexander EL, Antachopoulos C, Meletiadis J, Jabra-Rizk MA, Petraitis V, Roilides E, Walsh TJ. 2015. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms. J Antimicrob Chemother. 70:470–478. doi:https://doi.org/10.1093/jac/dku374
- Kovács R, Bozó A, Gesztelyi R, Domán M, Kardos G, Nagy F, Tóth Z, Majoros L. 2016. Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms. Int J Antimicrob Agents. 47:304–310. doi:https://doi.org/10.1016/j.ijantimicag.2016.01.007
- Kullberg BJ, Vasquez J, Mootsikapun P, Nucci M, Paiva J-A, Garbino J, Yan JL, Aram J, Capparella MR, Conte U, et al. 2017. Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials. J Antimicrob Chemother. 72:2368–2377. doi:https://doi.org/10.1093/jac/dkx116
- Langford ML, Atkin AL, Nickerson KW. 2009. Cellular interactions of farnesol, a quorum-sensing molecule produced by Candida albicans. Future Microbiol. 4:1353–1362. doi:https://doi.org/10.2217/fmb.09.98
- Leonhardt I, Spielberg S, Weber M, Albrecht-Eckardt D, Bläss M, Claus R, Barz D, Scherlach K, Hertweck C, Löffler J, et al. 2015. The fungal quorum-sensing molecule farnesol activates innate immune cells but suppresses cellular adaptive immunity. mBio. 6:e00143. doi:https://doi.org/10.1128/mBio.00143-15
- Louie A, Banerjee P, Drusano GL, Shayegani M, Miller MH. 1999. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans. Antimicrob Agents Chemother. 43:2841–2847. doi:https://doi.org/10.1128/AAC.43.12.2841
- Naglik JR, Conti HR, Whibley N, Coleman BM, Garg AV, Jaycox JR. 2015. Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis. PLoS One. 10:e0122807.
- Navarathna DH, Hornby JM, Krishnan N, Parkhurst A, Duhamel GE, Nickerson KW. 2007. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect Immun. 75:1609–1618. doi:https://doi.org/10.1128/IAI.01182-06
- Navarathna D, Nickerson KW, Duhamel GE, Jerrels TR, Petro TM. 2007. Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model. Infect Immun. 75:4006–4011. doi:https://doi.org/10.1128/IAI.00397-07
- Pammi M, Liang R, Hicks JM, Barrish J, Versalovic J. 2011. Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin. Pediatr Res. 70:578–583. doi:https://doi.org/10.1203/PDR.0b013e318232a984
- Ramage G, Saville SP, Wickes BL, López-Ribot JL. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol. 68:5459–5463. doi:https://doi.org/10.1128/AEM.68.11.5459-5463.2002
- Taff HT, Mitchell KF, Edward JA, Andes DR. 2013. Mechanisms of Candida biofilm drug resistance. Future Microbiol. 8:1325–1337. doi:https://doi.org/10.2217/fmb.13.101
- Takakura N, Sato Y, Ishibashi H, Oshima H, Uchida K, Yamaguchi H, Abe S. 2003. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol Immunol. 47:321–326. doi:https://doi.org/10.1111/j.1348-0421.2003.tb03403.x
- Whibley N, Tritto E, Traggiai E, Kolbinger F, Moulin P, Brees D, Coleman BM, Mamo AJ, Garg AV, Jaycox JR, et al. 2016. Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis. J Leukoc Biol. 99:1153–1164. doi:https://doi.org/10.1189/jlb.4A0915-428R
- Wong SS, Kao RY, Yuen KY, Wang Y, Yang D, Samaranayake LP. 2014. In vitro and in vivo activity of a novel antifungal small molecule against Candida infections. PLoS One. 9:e85836.
- Xia J, Fang Q, Xu W, Zhang Z, Xin W. 2017. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains. Biofouling. 33:283–293. [PubMed: 28317391] doi:https://doi.org/10.1080/08927014.2017.1295304